Clarivate Plc [NYSE: CLVT] gained 0.78% or 0.07 points to close at $9.07 with a heavy trading volume of 9709719 shares. The company report on December 6, 2022 that Clarivate Expands Real World Data and Analytics Solutions with Addition of U.S. Specialty Pharmacy Data.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the inclusion of linked specialty pharmacy claims data within real world data solutions. The new U.S. dataset will expand the real world data and analytics offerings from Clarivate. Researchers can access an in-depth view of high-cost medications and valuable insights into the patient’s treatment journey in chronic, complex and rare diseases, such as rheumatoid arthritis (e.g., Humira, Enbrel), inflammatory conditions (e.g., Dupixent, Otezla), and cancer (e.g., Xgeva, Xeloda).
Specialty drugs cover at least 20% of the market for chronic, complex and rare diseases. However, conventional claims data warehouses rarely include these high-cost medications, which limits the research potential of numerous diseases. Specialty pharmacy data enables life sciences professionals to:.
It opened the trading session at $8.98, the shares rose to $9.10 and dropped to $8.9275, the range by which the price of stock traded the whole day. The daily chart for CLVT points out that the company has recorded -33.89% loss over the past six months. However, it is still -13.38% lower than its most recent low trading price.
If we look at the average trading volume of 8.01M shares, CLVT reached to a volume of 9709719 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Clarivate Plc [CLVT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLVT shares is $12.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLVT stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Clarivate Plc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 13, 2022. While these analysts kept the previous recommendation, Citigroup dropped their target price from $35 to $16. The new note on the price target was released on February 04, 2022, representing the official price target for Clarivate Plc stock. Previously, the target price had yet another raise to $16, while Barclays analysts kept a Equal Weight rating on CLVT stock.
The Average True Range (ATR) for Clarivate Plc is set at 0.49, with the Price to Sales ratio for CLVT stock in the period of the last 12 months amounting to 2.42. The Price to Book ratio for the last quarter was 1.31, with the Price to Cash per share for the same quarter was set at 0.66. Price to Free Cash Flow for CLVT in the course of the last twelve months was 30.45 with Quick ratio for the last quarter at 0.90.
Trading performance analysis for CLVT stock
Clarivate Plc [CLVT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.52. With this latest performance, CLVT shares dropped by -9.30% in over the last four-week period, additionally sinking by -33.89% over the last 6 months – not to mention a drop of -62.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLVT stock in for the last two-week period is set at 42.87, with the RSI for the last a single of trading hit 40.79, and the three-weeks RSI is set at 43.67 for Clarivate Plc [CLVT]. The present Moving Average for the last 50 days of trading for this stock 9.65, while it was recorded at 9.04 for the last single week of trading, and 12.90 for the last 200 days.
Clarivate Plc [CLVT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Clarivate Plc [CLVT] shares currently have an operating margin of +2.39 and a Gross Margin at +37.99. Clarivate Plc’s Net Margin is presently recorded at -14.41.
Return on Equity for this stock declined to -2.58, with Return on Assets sitting at -1.55.
Clarivate Plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 0.90.
Clarivate Plc [CLVT]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLVT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clarivate Plc go to 10.50%.
An analysis of insider ownership at Clarivate Plc [CLVT]
There are presently around $5,090 million, or 93.60% of CLVT stock, in the hands of institutional investors. The top three institutional holders of CLVT stocks are: LEONARD GREEN & PARTNERS, L.P. with ownership of 116,666,507, which is approximately 0% of the company’s market cap and around 0.70% of the total institutional ownership; GENERATION INVESTMENT MANAGEMENT LLP, holding 46,076,543 shares of the stock with an approximate value of $417.91 million in CLVT stocks shares; and FARALLON CAPITAL MANAGEMENT LLC, currently with $367.75 million in CLVT stock with ownership of nearly 65.106% of the company’s market capitalization.
Positions in Clarivate Plc stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 154 institutional holders increased their position in Clarivate Plc [NYSE:CLVT] by around 104,220,777 shares. Additionally, 151 investors decreased positions by around 103,202,197 shares, while 30 investors held positions by with 353,716,552 shares. The mentioned changes placed institutional holdings at 561,139,526 shares, according to the latest SEC report filing. CLVT stock had 52 new institutional investments in for a total of 44,906,138 shares, while 48 institutional investors sold positions of 12,898,672 shares during the same period.